Presenting Nutrition Characteristics, Comorbidities and Outcomes of COVID-19 in African Humanitarian Settings: a Prospective Cohort Study in South Sudan and DRC
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- COVID-19
- Sponsor
- Johns Hopkins Bloomberg School of Public Health
- Enrollment
- 592
- Locations
- 3
- Primary Endpoint
- Hospitalization
- Status
- Completed
- Last Updated
- 4 years ago
Overview
Brief Summary
This study will characterize risk factors for poor COVID-19 outcomes (hospitalization, death) and clinical progression of hospitalized COVID-19 patients in South Sudan and Eastern Democratic Republic of the Congo.
Detailed Description
A prospective cohort design will be used to follow suspected, probable, and confirmed COVID-19 cases presenting for care at International Medical Corp \[supported\] health facilities in Juba, South Sudan and the Kivus in Eastern Democratic Republic of the Congo (DRC). This research seeks to assess risk factors for poor outcomes and characterize clinical disease progression of COVID-19 cases in resource-poor humanitarian contexts in Africa. Specifically, this study aims to characterize risk factors for poor COVID-19 outcomes, including both co-morbidities with evidence from high income settings, as well as prevalent conditions in humanitarian settings (e.g., acute malnutrition, malaria, HIV) for which data is not yet available. This research also aims to determine how the progression of confirmed COVID-19 cases in resource-poor African settings may differ from other settings where data are available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Suspected, probable, and confirmed COVID-19 cases presenting for care at participating health facilities (either by walk-in, referral or transfer) or identified by mobile contact tracing teams.
Exclusion Criteria
- •Individuals unable or unwilling to give informed consent (e.g., due to mental impairment)
Outcomes
Primary Outcomes
Hospitalization
Time Frame: patients will be followed until asymptomatic or deceased (an average of approximately 1 month)
Hospitalization due to COVID-19 (proportion of participants hospitalized and risk factors for hospitalization)
Mortality
Time Frame: patients will be followed until asymptomatic or deceased (an average of approximately 1 month)
Death due to COVID-19 (proportion of participants deceased and risk factors for death)